This review summarizes the genetic alterations and knockdown approaches published in
the literature to assess the role of key proteoglycans and glycoproteins in the structural …

This review refers to the origin and current state of the assessment of the SpondyloArthritis
International Society (ASAS) criteria for the classification of axial and peripheral …

Objective The aim of the present study was to evaluate the plasma vitamin D (vit D) levels
and their association with the disease activity in patients with ankylosing spondylitis (AS) …

Objective: To study chronic widespread pain (CWP) over time in patients with
spondyloarthritis (SpA), and to identify risk factors for development and persistence of CWP …

Background: The idea that undifferentiated spondyloarthritis (uSpA) represents the early
undifferentiated stage of ankylosing spondylitis (AS) and other well-defined SpA subtypes is …

Background Chronic pain, regional or widespread, is a frequent and multidimensional
symptom in arthritis. There is still limited information on chronic pain in spondyloarthritis …

Objective: Vedolizumab is a novel anti-inflammatory molecule that is currently being used in
the treatment of refractory inflammatory bowel disease. The mode of action is inhibiting the …

Inflammatory back pain (IBP) is a concept, which elements characterize the spinal
involvement of patients with ankylosing spondylitis (AS) and axial spondyloarthritis (axSpA) …

Spondyloarthritis (SpA) comprises a group of closely related but phenotypically distinct
chronic, inflammatory diseases including ankylosing spondylitis (AS), psoriatic SpA, SpA …

Clinical findings and responses to biologic agents are increasing the evidence that
undifferentiated spondyloarthritis (SpA) may represent the earliest stage of ankylosing …